Organogenesis Holdings Q4 2025 Earnings Preview
Source: SeekingAlpha
2026-02-25 17:35:30 ET
More on Organogenesis Holdings
- Organogenesis: High-Tech Skin Substitute Company On Sale
- Organogenesis drops as Medicare to pull skin substitute LCDs (update)
- Organogenesis starts rolling submission for ReNu allograft for knee arthritis
- Seeking Alpha’s Quant Rating on Organogenesis Holdings
- Historical earnings data for Organogenesis Holdings
Read the full article on Seeking Alpha
For further details see:
Organogenesis Holdings Q4 2025 Earnings Preview
Organogenesis Holdings Inc.
NASDAQ: ORGO
ORGO Trading
-7.09% G/L:
$2.75 Last:
257,923 Volume:
$2.86 Open:
ORGO Latest News
February 26, 2026 04:05:00 pm
Organogenesis Holdings Inc. Reports Fourth Quarter 2025 Financial Results, Posts Record Revenue
February 19, 2026 04:05:00 pm
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026
ORGO Stock Data
$490,515,429
46,830,580
2.02%
145
N/A
Pharmaceuticals
Healthcare
US
Canton
